Successful re-treatment of a relapsed V600E mutated HCL patient with low-dose vemurafenib.

Bailleux C, Robert G, Ginet C, Re D, Thyss A, Sudaka I, Peyrottes I, Hofman P, Auberger P, Peyrade F

Open source

DOI
10.18632/oncoscience.111
Published
2015
Container
Oncoscience
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.18632/oncoscience.111,
  title = {Successful re-treatment of a relapsed V600E mutated HCL patient with low-dose vemurafenib.},
  author = {Bailleux C and Robert G and Ginet C and Re D and Thyss A and Sudaka I and Peyrottes I and Hofman P and Auberger P and Peyrade F},
  year = {2015},
  journal = {Oncoscience},
  doi = {10.18632/oncoscience.111},
  url = {https://doi.org/10.18632/oncoscience.111}
}

RIS

TY  - JOUR
TI  - Successful re-treatment of a relapsed V600E mutated HCL patient with low-dose vemurafenib.
AU  - Bailleux C
AU  - Robert G
AU  - Ginet C
AU  - Re D
AU  - Thyss A
AU  - Sudaka I
AU  - Peyrottes I
AU  - Hofman P
AU  - Auberger P
AU  - Peyrade F
PY  - 2015
JO  - Oncoscience
DO  - 10.18632/oncoscience.111
UR  - https://doi.org/10.18632/oncoscience.111
ER  - 

APA

C, B., G, R., C, G., D, R., A, T., I, S., I, P., P, H., P, A., & F, P. (2015). Successful re-treatment of a relapsed V600E mutated HCL patient with low-dose vemurafenib.. Oncoscience. https://doi.org/10.18632/oncoscience.111

Source records